In Vivo Analysis of T lymphocytes in the Persistently Infected CNS
In Vivo Analysis of T lymphocytes in the Persistently Infected CNS
批准号:
8026029
负责人:
MICHAEL B OLDSTONE
金额:
$45.55万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-03-01 至 2013-02-28
关键词:
AddressAdenovirusesAdoptive ImmunotherapyAffectAntigensAstrocytesBehavioralBiological ModelsBrainCentral Nervous System Viral DiseasesCessation of lifeChronic PhaseCytopathologyEffectivenessEnvironmentEpitopesFailureHIVHealthHerpesviridaeHumanHuman T-lymphotropic virus 1ImmuneImmune responseImmune systemImmunityImmunosuppressive AgentsInfectionJC VirusLymphocytic choriomeningitis virusMajor Histocompatibility ComplexMeasles virusModelingModusMusNeuraxisNeurologic DysfunctionsNeuronsPeripheralPhasePopulationPricePropertyRecovery of FunctionRecruitment ActivityRegulationResearchResearch PersonnelRouteSourceT cell responseT memory cellT-LymphocyteTimeTissuesToxic effectTropismViralVirusVirus Diseasescytokinedesignexhaustionimmunopathologyin vivoinsightneurobehavioralneurotropic virusnovelolfactory bulbpathogenpressurepreventprogramspurgeresponsestem
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The central nervous system (CMS) poses a unique challenge to the immune system, as it is considered an immunologically specialized compartment that resides behind a non-fenestrated barrier and significantly limits the expression of antigen-presenting machinery. Because the CNS is compartmentalized and imposes strict regulatory mechanisms on the adaptive immune system, a multitude of pathogens that infect humans (e.g. HIV, herpes virus, measles virus, HTLV-1, JC virus, etc.) are capable of establishing persistence in the CNS. These persistent infections can give rise to severe behavioral alterations and neurological dysfunction, which adversely affects human health. Persistent infections that gain access to the CNS often do so by first establishing persistence in the periphery. This common scenario consequently presents biomedical researchers with the challenge of eradicating the pathogen from both the periphery as well as the CNS. Given that the CNS provides such a favorable environment to viruses seeking persistence, we postulate that achieving clearance from this specialized compartment will be far more challenging than from peripheral tissues. The proposed study will explore a murine model system in which an immunosuppressive virus is introduced through a peripheral route and then establishes prolonged persistence in the CNS despite the eventual clearance from the periphery. Clearance from the periphery coincides with a functional reactivation of virus-specific T cells (a scenario we hope to achieve in humans), yet this response is unable to prevent prolonged viral persistence within the CNS. Importantly, administration of exogenous memory T lymphocytes at the peak of CNS viral infection results in efficient clearance of the virus from both the periphery and the CNS. Thus, an adoptively transferred population of memory T lymphocytes can achieve successful clearance despite an inadequate endogenous immune response. The proposed study is designed to significantly advance our understanding of T cell immunity to persistent viral infections in the CNS by establishing the shortcomings of the endogenous T cell response (Specific Aim#1) and the modus operand of a highly successful adoptive response (Specific Aim#2). The main objective of this research is mechanistically define the factors that give rise to successful CNS viral clearance so that we are better able to supplement a failing (or inadequate) endogenous response.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Host Genetic Factors to Combat Lassa Hemorrhagic Fever
-
批准号:8573827
-
项目类别:
-
资助金额:$44.53万
-
财政年份:2013
-
负责人:MICHAEL B OLDSTONE
-
依托单位:
Host Genetic Factors to Combat Lassa Hemorrhagic Fever
-
批准号:8711266
-
项目类别:
-
资助金额:$47.38万
-
财政年份:2013
-
负责人:MICHAEL B OLDSTONE
-
依托单位:
Host Genetic Factors to Combat Lassa Hemorrhagic Fever
-
批准号:9118852
-
项目类别:
-
资助金额:$48.13万
-
财政年份:2013
-
负责人:MICHAEL B OLDSTONE
-
依托单位:
Pathogenesis of Acute Respiratory Diseases: SARS and INFLUENZA
-
批准号:8609326
-
项目类别:
-
资助金额:$32.47万
-
财政年份:2012
-
负责人:MICHAEL B OLDSTONE
-
依托单位:
Novel Chemical and Immunological Approaches to Influenza Therapy
-
批准号:7288013
-
项目类别:
-
资助金额:$160.69万
-
财政年份:2007
-
负责人:MICHAEL B OLDSTONE
-
依托单位:
Novel Chemical and Immunological Approaches to Influenza Therapy
-
批准号:8076285
-
项目类别:
-
资助金额:$163.57万
-
财政年份:2007
-
负责人:MICHAEL B OLDSTONE
-
依托单位:
Novel Chemical and Immunological Approaches to Influenza Therapy
-
批准号:7864328
-
项目类别:
-
资助金额:$165.57万
-
财政年份:2007
-
负责人:MICHAEL B OLDSTONE
-
依托单位:
In Vivo Analysis of T lymphocytes in the Persistently Infected CNS
-
批准号:7570017
-
项目类别:
-
资助金额:$46.47万
-
财政年份:2007
-
负责人:MICHAEL B OLDSTONE
-
依托单位:
Novel Chemical and Immunological Approaches to Influenza Therapy
-
批准号:7626430
-
项目类别:
-
资助金额:$162.72万
-
财政年份:2007
-
负责人:MICHAEL B OLDSTONE
-
依托单位:
Novel Chemical and Immunological Approaches to Influenza Therapy
-
批准号:7433177
-
项目类别:
-
资助金额:$158.34万
-
财政年份:2007
-
负责人:MICHAEL B OLDSTONE
-
依托单位:
In Vivo Analysis of T lymphocytes in the Persistently Infected CNS
-
批准号:7767714
-
项目类别:
-
资助金额:$46.01万
-
财政年份:2007
-
负责人:MICHAEL B OLDSTONE
-
依托单位:
Therapeutics to Prevent/Treat Lassa Fever Virus
-
批准号:7064252
-
项目类别:
-
资助金额:$45.82万
-
财政年份:2004
-
负责人:MICHAEL B OLDSTONE
-
依托单位:
Therapeutics to Prevent/Treat Lassa Fever Virus
-
批准号:7218663
-
项目类别:
-
资助金额:$44.49万
-
财政年份:2004
-
负责人:MICHAEL B OLDSTONE
-
依托单位:
Therapeutics to Prevent/Treat Lassa Fever Virus
-
批准号:7578818
-
项目类别:
-
资助金额:$47.48万
-
财政年份:2004
-
负责人:MICHAEL B OLDSTONE
-
依托单位:
Therapeutics to Prevent/Treat Lassa Fever Virus
-
批准号:6817720
-
项目类别:
-
资助金额:$31.28万
-
财政年份:2004
-
负责人:MICHAEL B OLDSTONE
-
依托单位:
Therapeutics to Prevent/Treat Lassa Fever Virus
-
批准号:6891327
-
项目类别:
-
资助金额:$46.93万
-
财政年份:2004
-
负责人:MICHAEL B OLDSTONE
-
依托单位:
Therapeutics to Prevent/Treat Lassa Fever Virus
-
批准号:7842621
-
项目类别:
-
资助金额:$47.48万
-
财政年份:2004
-
负责人:MICHAEL B OLDSTONE
-
依托单位:
Therapeutics to Prevent/Treat Lassa Fever Virus
-
批准号:7394464
-
项目类别:
-
资助金额:$44.07万
-
财政年份:2004
-
负责人:MICHAEL B OLDSTONE
-
依托单位:
Therapeutics to Prevent/Treat Lassa Fever Virus
-
批准号:6668779
-
项目类别:
-
资助金额:$46.93万
-
财政年份:2003
-
负责人:MICHAEL B OLDSTONE
-
依托单位:
Pathogenesis Studies in Scrapie (TSE Diseases)
-
批准号:6702502
-
项目类别:
-
资助金额:$34.72万
-
财政年份:2003
-
负责人:MICHAEL B OLDSTONE
-
依托单位:
海外基金